Skip to main content
. 2019 Feb 3;17(2):319–328. doi: 10.1111/jth.14364

Figure 4.

Figure 4

Relative effect of rosuvastatin treatment on thrombin generation potential by subgroups. The relative effect of rosuvastatin treatment on endogenous thrombin potential (A) and on thrombin peak (B) in prespecified subgroups: sex (female/male), type of VTE (DVT/PE), VTE classification (provoked/unprovoked) and presence of cardiovascular (CV) risk factors (no CV risk/CV risk) compared with non‐statin treatment.